nRichDX
PrivateLast Round
VC Round
Jun 17, 2020
Company Overview
nRichDX is a life sciences company that provides automated sample preparation systems and kits for liquid biopsy applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
nRichDX Comparables
Compare nRichDX with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avant Genomics | 86% | |
| Promega Corporation | 77% | |
| Qiagen | 74% | |
nRichDX Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 17, 2020 | ||||
| VC Round | Jun 27, 2018 | ||||
| VC Round | Nov 7, 2016 | ||||
| VC Round | Jul 16, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2024
Grew 33% QoQ from 15 to 20 employees.
- Jul 16, 2015
$2.25M round raised
nRichDX Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about nRichDX's valuation, stock price, and market status.